STANFORD UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-11-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.stanford.edu
Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation
Phase 2
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2012-06-13
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 13
- Registration Number
- NCT00186420
- Locations
- 🇺🇸
Stanford University Cancer Center, Stanford, California, United States
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies
Phase 2
Completed
- Conditions
- Blood CancerLeukemia
- Interventions
- Drug: Anti-thymocyte globulin (ATG)Radiation: Total Lymphoid Irradiation (TLI)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2021-06-29
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 303
- Registration Number
- NCT00185640
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
Not Applicable
Completed
- Conditions
- Depressive Disorder, Major
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 18
- Registration Number
- NCT00186264
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
Phase 2
Completed
- Conditions
- Blood CancerMyelodysplastic SyndromesMyeloproliferative Disorders
- Interventions
- Procedure: Total Lymphoid Irradiation (TLI)Procedure: Anti-Thymocyte Globulin as Conditioning (ATG)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 77
- Registration Number
- NCT00185796
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
An Interactive Program to Improve Care for Children With CF
Not Applicable
Completed
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-10-05
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 60
- Registration Number
- NCT00185549
- Locations
- 🇺🇸
Lucile Packard Children's Hospital, Palo Alto, California, United States
A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-07-25
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 23
- Registration Number
- NCT00186108
- Locations
- 🇺🇸
Stanford University Cancer Center, Stanford, California, United States
Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer?
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2019-11-22
- Lead Sponsor
- Stanford University
- Registration Number
- NCT00186602
- Locations
- 🇺🇸
WomenCARE, Santa Cruz, California, United States
Microarray Analysis of Gene Expression in Prostate Tissues
Active, not recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 867
- Registration Number
- NCT00186368
- Locations
- 🇺🇸
Stanford University Cancer Center, Stanford, California, United States
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
Phase 2
Completed
- Conditions
- Graft vs Host DiseaseBlood and Marrow Transplant (BMT)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2020-04-09
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 30
- Registration Number
- NCT00186667
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
Terminated
- Conditions
- Leukemia, Lymphocytic, AcuteLeukemia Acute Promyelocytic Leukemia (APL)Leukemia Acute Lymphoid Leukemia (ALL)LeukemiaLeukemia Chronic Lymphocytic Leukemia (CLL)Leukemia Chronic Myelogenous Leukemia (CML)Leukemia Acute Myeloid Leukemia (AML)
- Interventions
- Procedure: Allogeneic hematopoietic cell transplantation
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2016-06-16
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 88
- Registration Number
- NCT00185523
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States